Dyne Therapeutics, Inc. (DYN) vs Enliven Therapeutics, Inc. (ELVN)
A side-by-side comparison of Dyne Therapeutics, Inc. and Enliven Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DYN
Dyne Therapeutics, Inc.
$15.41HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
ELVN
Enliven Therapeutics, Inc.
$43.04HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — DYN vs ELVN
growth of $100 · dividends reinvested · last 6yDYN -35.4% (-7.0%/yr)ELVN -50.5% (-11.1%/yr)DYN compounded faster over this window
DYN ELVN
DYN vs ELVN: by the numbers
- •ELVN is the larger company ($3.07B vs $2.88B market cap).
Metrics side by side
Valuation
| Metric | DYN | ELVN |
|---|---|---|
| P/B ratio | 4.10 | 3.43 |
Profitability
| Metric | DYN | ELVN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -73.97% | -11.83% |
| ROIC | -58.28% | -13.88% |
Growth (annualized)
| Metric | DYN | ELVN |
|---|---|---|
| Total return CAGR (5Y) | -0.38% | 24.57% |
Frequently asked
- How have DYN and ELVN total returns compared?
- Over the past 5 years, DYN delivered -0.38% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.